Loading
Latest filing published 18 Jun 2025 for Oragenics INC, €7,768.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Odyssey Health, Inc. on record concern Oragenics Inc. The record holds 4 filings, for trades running from 13 June 2025 to 18 June 2025.
Every open-market trade on record is a sale: 4 sales worth €64k.
On 18 June 2025 came the latest disclosure, an open-market sale for €19k in Oragenics Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations